We previously found that higher MD was associated with HER2-enriched and luminal B breast subtypes among Chinese breast cancer patients [8, 20], while reduced TDLU involution was associated with TNBC/basal-like breast subtypes among European, Black, and Chinese women [10–12]. Here, ERBB2 is linked to breast cancer.